FDA

18 February 2021

The FDA MyStudies app

21 December 2020

Real-world evidence in regulatory decision making

6 November 2020

FDA staff back controversial Alzheimer’s drug

12 October 2020

FDA benefit-risk frameworks for drug approval

21 February 2020

FDA releases list of evidence-based pharmacogenetic variants